Axonal cytoskeleton changes in experimental optic neuritis

Brain Research

Volumn 824, Issue 2, 1999, Pages 204-217

  Zhu, Bing ^a   Moore, G R Wayne ^a   Zwimpfer, Thomas J ^a   Kastrukoff, Lorne F ^a   Dyer, Jason K ^a   Steeves, John D ^a   Paty, Donald W ^a   Cynader, Max S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anti galactocerebroside; Axonal degeneration; Macrophage; Microtubule; Multiple sclerosis; Neurofilament protein

Indexed keywords

GALACTOSYLCERAMIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOSKELETON; DEMYELINATION; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROTUBULE; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NEUROFILAMENT; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; AXONS; CYTOSKELETON; DEMYELINATING DISEASES; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTIONS; MICROSCOPY, ELECTRON; MICROTUBULES; NEUROFILAMENT PROTEINS; OPTIC NEURITIS; RATS; RATS, WISTAR;

EID: 0033541567     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01191-9     Document Type: Article

References (69)

1. D.L. Arnold, G.T. Riess, P.M. Matthews, G.S. Francis, D.L. Collins, C. Wolfson, J.P. Antel, Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis, Ann. Neurol. 36 (1994) 76-82.
2. D. Barnes, P.M. Munro, B.D. Youl, J.W. Prineas, W.I. McDonald, The longstanding MS lesion. A quantitative MRI and electron microscopic study, Brain 114 (1991) 1271-1280.
3. A. Brown, D.E. McFarlin, C.S. Raine, Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse, Lab. Invest. 46 (1982) 171-185.
4. W. Bruck, The role of macrophages in Wallerian degeneration, Brain Pathol. 7 (1997) 741-752.
5. W.M. Carroll, A.R. Jennings, F.L. Mastaglia, Experimental optic neuropathy - A model for combined morphological and electrophysiological studies, in: J.H. Tyrer, M.J. Eadie (Eds.), Clinical and Experimental Neurology, ADIS Health Science Press, New York, 1982, pp. 17-28.
6. W.M. Carroll, A.R. Jennings, F.L. Mastaglia, Experimental demyelinating optic neuropathy induced by intra-neural injection of galactocerebroside antiserum, J. Neurol. Sci. 65 (1984) 125-135.
7. S.S. Chin, R.K. Liem, Transfected rat high-molecular-weight neurofilament (NF-H) coassembles with vimentin in a predominantly nonphosphorylated form, J. Neurosci. 10 (1990) 3714-3726.
8. S.M. Chou, H.S. Wang, K. Komai, Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study, J. Chem. Neuroanat. 10 (1996) 249-258.
9. J.S. Cole, A. Messing, J.Q. Trojanowski, V.M. Lee, Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice, J. Neurosci. 14 (1994) 6956-6966.
10. R.J. Colello, M.E. Schwab, A role for oligodendrocytes in the stabilization of optic axon numbers, J. Neurosci. 14 (1994) 6446-6452.
11. D. Dahl, G. Perides, A. Bignami, Axonal regeneration in old multiple sclerosis plaques. Immunohistochemical study with monoclonal antibodies to phosphorylated and non-phosphorylated neurofilament proteins, Acta Neuropathol. 79 (1989) 154-159.
12. C.A. Davie, G.J. Barker, S. Webb, P.S. Tofts, A.J. Thompson, A.E. Harding, W.I. McDonald, D.H. Miller, Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss, Brain 118 (1995) 1583-1592.
13. N. De Stefano, P.M. Matthews, S. Narayanan, G.S. Francis, J.P. Antel, D.L. Arnold, Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient, Neurology 49 (1997) 1138-1141.
14. S. deWaegh, S.T. Brady, Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions, J. Neurosci. 10 (1990) 1855-1865.
15. S. deWaegh, V.M. Lee, S.T. Brady, Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells, Cell 68 (1992) 451-463.
16. A. Duncan, M. Ibrahim, M. Berry, A.M. Butt, Transfer of horseradish peroxidase from oligodendrocyte to axon in the myelinating neonatal rat optic nerve: artefact or transcellular exchange?, Glia 17 (1996) 349-355.
17. J.K. Dyer, J.A. Bourque, J.D. Steeves, Regeneration of brainstemspinal axons after immunological disruption of myelin in adult rat, Exp. Neurol. 154 (1998) 12-22.
18. B. Ferguson, M.K. Matyszak, M.M. Esiri, V.H. Perry, Axonal damage in acute multiple sclerosis lesions, Brain 120 (1997) 393-399.
19. R. Fern, B.R. Ransom, S.G. Waxman, Voltage-gated calcium channels in CNS white matter: role in anoxic injury, J. Neurophys. 74 (1995) 369-377.
20. L.M. Fleming, G.V. Johnson, Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP, Biochem. J. 309 (1995) 41-47.
21. L. Frisen, W.F. Hoyt, Insidious atrophy of retinal nerve fibers in multiple sclerosis. Funduscopic identification in patients with and without visual complaints, Arch. Ophthalmol. 92 (1974) 91-97.
22. D.D. Gaton, A. Solomon, E. Skutelsky, M. Wolman, Does a cytoplasmic bridge connect the CNS axon with the inner loop of myelin?, Cell. Mol. Biol. 38 (1992) 597-599.
23. Y. Gonda, K. Nishizawa, S. Ando, S. Kitamura, Y. Minoura, Y. Nishi, M. Inagaki, Involvement of protein kinase C in the regulation of assembly-disassembly of neurofilaments in vitro, Biochem. Biophys. Res. Commun. 167 (1990) 1316-1325.
24. J.A. Greenwood, J.C. Troncoso, A.C. Costello, G.V. Johnson, Phosphorylation modulates calpain-mediated proteolysis and calmodulin binding of the 200-kDa and 160-kDa neurofilament proteins, J. Neurochem. 61 (1993) 191-199.
25. J. Guy, E.A. Ellis, E. Tark, G.M. Hope, N.A. Rao, Axonal transport reductions in acute experimental allergic encephalomyelitis: qualitative analysis of the optic nerve, Curr. Eye Res. 8 (1989) 261-269.
26. J. Guy, E.A. Ellis, G.M. Hope, S. Emerson, Maintenance of myelinated fibre g ratio in acute experimental allergic encephalomyelitis, Brain 114 (1991) 281-289.
27. N. Hirokawa, Molecular architecture and dynamics of neuronal cytoskeketon, in: R.D. Borgoyen (Ed.), The Neuronal Cytoskeleton, Wiley, New York, 1991, pp. 5-74.
28. S. Hisanaga, N. Hirokawa, The effects of dephosphorylation on the structure of the projections of neurofilament, J. Neurosci. 9 (1989) 959-966.
29. P.N. Hoffman, R.J. Lasek, The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons, J. Cell Biol. 66 (1975) 351-366.
30. S.T. Hsieh, G.J. Kidd, T.O. Crawford, Z. Xu, W.M. Lin, B.D. Trapp, D.W. Cleveland, J.W. Griffin, Regional modulation of neurofilament organization by myelination in normal axons, J. Neurosci. 14 (1994) 6392-6401.
31. I. Hutchinson, Transplantation and rejection, in: I. Roitt, J. Brostoff, D. Male (Eds.), Immunology, Times Mirro International Publishers, Barcelona, 1996, pp. 26-27.
32. H.G. Jenkins, H. Ikeda, Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve, J. Neurol. Sci. 108 (1992) 99-104.
33. L.L. Kirkpatrick, S.T. Brady, Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells, J. Neurosci. 14 (1994) 7440-7450.
34. H. Lassmann, G. Suchanek, K. Ozawa, Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis, Ann. Neurol. 36 (1994) s42-6.
35. J.M. Litersky, G.V. Johnson, Phosphorylation of tau in situ: inhibition of calcium-dependent proteolysis, J. Neurochem. 65 (1995) 903-911.
36. J.M. Litersky, G.V. Johnson, R. Jakes, M. Goedert, M. Lee, P. Seubert, Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356, Biochem. J. 361 (1996) 655-660.
37. E.M. Mandelkow, J. Biernat, G. Drewes, N. Gustke, B. Trinczek, E. Mandelkow, Tau domains, phosphorylation, and interactions with microtubules, Neurobiol. Aging 16 (1995) 355-362, [Review] [57 Refs.].
38. M. Mata, N. Kupina, D.J. Fink, Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier, J. Neurocytol. 21 (1992) 199-210.
39. W.I. McDonald, Rachelle Fishman-Matthew Moore Lecture. The pathological and clinical dynamics of multiple sclerosis, J. Neuropath. Exp. Neur. 53 (1994) 338-343, [Review] [50 Refs.].
40. J.E. Merrill, E.N. Benveniste, Cytokines in inflammatory brain lesions: helpful and harmful, Trends Neurosci. 19 (1996) 331-338, [Review] [68 Refs.].
41. S. Narayanan, L. Fu, E. Pioro, S.N. De, D.L. Collins, G.S. Francis, J.P. Antel, P.M. Matthews, D.L. Arnold, Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions, Ann. Neurol. 41 (1997) 385-391.
42. R.A. Nixon, Proteolysis of neurofilaments, in: C.A. Marotta (Ed.), Neurofilaments, University of Minnesota Press, Minneapolis, 1983, pp. 117-154.
43. R.A. Nixon, P.A. Paskevich, R.K. Sihag, C.Y. Thayer, Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber, J. Cell Biol. 126 (1994) 1031-1046.
44. H.C. Pant, Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain, Biochem. J. 256 (1988) 665-668.
45. V.F. Pessoa, H. Ikeda, Increase in axonal transport in demyelinating optic nerve fibres in the mouse infected with Semliki Forest virus, Brain 107 (1984) 433-446.
46. H.C. Powell, R.R. Myers, A.P. Mizisin, T. Olee, S.W. Brostoff, Response of the axon and barrier endothelium to experimental allergic neuritis induced by autoreactive T cell lines, Acta Neuropathol. 82 (1991) 364-377.
47. J.W. Prineas, F. Connell, The fine structure of chronically active multiple sclerosis plaques, Neurology 28 (1978) 68-75.
48. C.S. Raine, A.H. Cross, Axonal dystrophy as a consequence of long-term demyelination, Lab. Invest. 60 (1989) 714-725.
49. N.A. Rao, Chronic experimental allergic optic neuritis, Invest. Ophthalmol. Vis. Sci. 20 (1981) 159-172.
50. N.A. Rao, J. Guy, P.S. Sheffield, Effects of chronic demyelination on axonal transport in experimental allergic optic neuritis, Invest. Ophthalmol. Vis. Sci. 21 (1981) 606-611.
51. K.E. Reagan, K.R. Wilmarth, M.A. Friedman, D.M. Abou, In vitro calcium and calmodulin-dependent kinase-mediated phosphorylation of rat brain and spinal cord neurofilament proteins is increased by glycidamide administration, Brain Res. 671 (1995) 12-20.
52. A. Reles, R.L. Friede, Axonal cytoskeleton at the nodes of Ranvier, J. Neurocytol. 20 (1991) 450-458.
53. M. Rodriguez, B. Scheithauer, Ultrastructure of multiple sclerosis, Ultrastruct. Pathol. 18 (1994) 3-13.
54. I. Sanchez, L. Hassinger, P.A. Paskevich, H.D. Shine, R.A. Nixon, Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation, J. Neurosci. 16 (1996) 5095-5105.
55. W.W. Schlaepfer, U.-J.P. Zimmerman, The degradation of neurofilaments by calpains, in: R.L. Mellellgren, T. Murachi (Eds.), Intracellular Calcium-dependent Proteolysis, 1990, pp. 241-249.
56. R.C. Sergott, M.J. Brown, D.H. Silberberg, R.P. Lisak, Antigalactocerebroside serum demyelinates optic nerve in vivo, J. Neurol. Sci. 64 (1984) 297-303.
57. R.K. Sihag, A.Y. Jeng, R.A. Nixon, Phosphorylation of neurofilament proteins by protein kinase C, FEBS Letters 233 (1988) 181-185.
58. T.J. Singh, J.Z. Wang, M. Novak, E. Kontzekova, I.I. Grundke, K. Iqbal, Calcium/calmodulin-dependent protein kinase II phosphorylates tau at Ser-262 but only partially inhibits its binding to microtubules, FEBS Letters 387 (1996) 145-148.
59. R. Starr, B. Attema, G.H. DeVries, M.J. Monteiro, Neurofilament phosphorylation is modulated by myelination, J. Neurosci. Res. 44 (1996) 328-337.
60. T. Tabira, K. Sakai, Demyelination induced by T cell lines and clones specific for myelin basic protein in mice, Lab. Invest. 56 (1987) 518-525.
61. E.M. Tansey, H. Ikeda, The relationship between axonal transport of protein and demyelination in the optic nerves of mice infected with Semliki Forest virus, Brain Res. 397 (1986) 9-15.
62. M. Tomita, Y. Fukuuchi, Leukocytes, macrophages and secondary brain damage following cerebral ischemia, Acta Neurochir. Suppl. 66 (1996) 32-39, [Review] [58 Refs.].
63. B.D. Trapp, J. Peterson, R.M. Ransohoff, R. Rudick, S. Mörk, L. Bö, Axonal transection in the lesions of multiple sclerosis, N. Eng. J. Med. 338 (1998) 278-285.
64. S.G. Waxman, J.A. Black, B.R. Ransom, P.K. Stys, Protection of the axonal cytoskeleton in anoxic optic nerve by decreased extracellular calcium, Brain Res. 614 (1993) 137-145.
65. S.G. Waxman, J.M. Ritchie, Molecular dissection of the myelinated axon, Ann. Neurol. 33 (1993) 121-136.
66. S.R. White, R.M. Bowker, Retrograde transport of horseradish peroxidase is specifically impaired in bulbospinal serotonin axons during experimental allergic encephalomyelitis, J. Neuroimmunol. 18 (1988) 75-86.
67. S.R. White, D. Vyas, D. Bieger, Serotonin immunoreactivity in spinal cord axons and terminals of rodents with experimental allergic encephalomyelitis, Neurosci. 16 (1985) 701-709.
68. J.S. Whitson, A. Kampfl, X. Zhao, C.E. Dixon, R.L. Hayes, Brief potassium depolarization decreases levels of neurofilament proteins in CNS culture, Brain Res. 694 (1995) 213-222.
69. L.S. Yang, R.H. Ksiezak, Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments, Eur. J. Biochem. 233 (1995) 9-17.